COLOPLAST-B (CBHD.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:CBHD - DK0060448595 - Common Stock
78.68 EUR
+1.8 (+2.34%)
CBHD gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 65 industry peers in the Health Care Equipment & Supplies industry. CBHD scores excellent on profitability, but there are some minor concerns on its financial health. CBHD has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
CBHD had positive earnings in the past year.
CBHD had a positive operating cash flow in the past year.
CBHD had positive earnings in each of the past 5 years.
Each year in the past 5 years CBHD had a positive operating cash flow.
1.2 Ratios
CBHD has a Return On Assets of 7.52%. This is in the better half of the industry: CBHD outperforms 80.00% of its industry peers.
With an excellent Return On Equity value of 22.55%, CBHD belongs to the best of the industry, outperforming 89.23% of the companies in the same industry.
CBHD's Return On Invested Capital of 12.65% is amongst the best of the industry. CBHD outperforms 90.77% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CBHD is above the industry average of 9.72%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.52% | ||
| ROE | 22.55% | ||
| ROIC | 12.65% |
ROA(3y)9.32%
ROA(5y)14.2%
ROE(3y)26.12%
ROE(5y)38.84%
ROIC(3y)13.59%
ROIC(5y)18.83%
1.3 Margins
CBHD has a better Profit Margin (13.04%) than 73.85% of its industry peers.
In the last couple of years the Profit Margin of CBHD has declined.
With an excellent Operating Margin value of 27.52%, CBHD belongs to the best of the industry, outperforming 95.38% of the companies in the same industry.
In the last couple of years the Operating Margin of CBHD has declined.
The Gross Margin of CBHD (67.97%) is better than 72.31% of its industry peers.
In the last couple of years the Gross Margin of CBHD has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 27.52% | ||
| PM (TTM) | 13.04% | ||
| GM | 67.97% |
OM growth 3Y-3.48%
OM growth 5Y-2.71%
PM growth 3Y-14.46%
PM growth 5Y-10.44%
GM growth 3Y-0.39%
GM growth 5Y-0.01%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CBHD is creating value.
The number of shares outstanding for CBHD remains at a similar level compared to 1 year ago.
CBHD has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CBHD has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 3.98 indicates that CBHD is not in any danger for bankruptcy at the moment.
The Altman-Z score of CBHD (3.98) is better than 67.69% of its industry peers.
CBHD has a debt to FCF ratio of 4.34. This is a neutral value as CBHD would need 4.34 years to pay back of all of its debts.
CBHD's Debt to FCF ratio of 4.34 is in line compared to the rest of the industry. CBHD outperforms 56.92% of its industry peers.
A Debt/Equity ratio of 1.24 is on the high side and indicates that CBHD has dependencies on debt financing.
The Debt to Equity ratio of CBHD (1.24) is worse than 83.08% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.24 | ||
| Debt/FCF | 4.34 | ||
| Altman-Z | 3.98 |
ROIC/WACC2.19
WACC5.78%
2.3 Liquidity
A Current Ratio of 1.61 indicates that CBHD should not have too much problems paying its short term obligations.
CBHD has a Current ratio of 1.61. This is comparable to the rest of the industry: CBHD outperforms 46.15% of its industry peers.
CBHD has a Quick Ratio of 1.00. This is a normal value and indicates that CBHD is financially healthy and should not expect problems in meeting its short term obligations.
CBHD's Quick ratio of 1.00 is on the low side compared to the rest of the industry. CBHD is outperformed by 60.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.61 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
CBHD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -20.93%.
CBHD shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -2.02% yearly.
CBHD shows a small growth in Revenue. In the last year, the Revenue has grown by 3.12%.
Measured over the past years, CBHD shows a quite strong growth in Revenue. The Revenue has been growing by 8.49% on average per year.
EPS 1Y (TTM)-20.93%
EPS 3Y-7.04%
EPS 5Y-2.02%
EPS Q2Q%-20.03%
Revenue 1Y (TTM)3.12%
Revenue growth 3Y7.27%
Revenue growth 5Y8.49%
Sales Q2Q%0.1%
3.2 Future
The Earnings Per Share is expected to grow by 16.78% on average over the next years. This is quite good.
The Revenue is expected to grow by 7.10% on average over the next years.
EPS Next Y45.69%
EPS Next 2Y27.02%
EPS Next 3Y21.55%
EPS Next 5Y16.78%
Revenue Next Year5.7%
Revenue Next 2Y6.56%
Revenue Next 3Y6.93%
Revenue Next 5Y7.1%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 33.06 indicates a quite expensive valuation of CBHD.
CBHD's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 26.41. CBHD is valued slightly more expensive when compared to this.
The Price/Forward Earnings ratio is 22.71, which indicates a rather expensive current valuation of CBHD.
CBHD's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 35.40. CBHD is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.06 | ||
| Fwd PE | 22.71 |
4.2 Price Multiples
CBHD's Enterprise Value to EBITDA ratio is in line with the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CBHD indicates a somewhat cheap valuation: CBHD is cheaper than 75.38% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 23.67 | ||
| EV/EBITDA | 15.75 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of CBHD may justify a higher PE ratio.
A more expensive valuation may be justified as CBHD's earnings are expected to grow with 21.55% in the coming years.
PEG (NY)0.72
PEG (5Y)N/A
EPS Next 2Y27.02%
EPS Next 3Y21.55%
5. Dividend
5.1 Amount
CBHD has a Yearly Dividend Yield of 3.94%.
CBHD's Dividend Yield is rather good when compared to the industry average which is at 2.15. CBHD pays more dividend than 98.46% of the companies in the same industry.
CBHD's Dividend Yield is rather good when compared to the S&P500 average which is at 2.32.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.94% |
5.2 History
The dividend of CBHD has a limited annual growth rate of 5.30%.
Dividend Growth(5Y)5.3%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
CBHD pays out 136.36% of its income as dividend. This is not a sustainable payout ratio.
The dividend of CBHD is growing, but earnings are growing more, so the dividend growth is sustainable.
DP136.36%
EPS Next 2Y27.02%
EPS Next 3Y21.55%
FRA:CBHD (12/4/2025, 7:00:00 PM)
78.68
+1.8 (+2.34%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners29.27%
Inst Owner ChangeN/A
Ins Owners29.79%
Ins Owner ChangeN/A
Market Cap16.54B
Revenue(TTM)27.87B
Net Income(TTM)3.64B
Analysts68.46
Price Target93.67 (19.05%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.94% |
Yearly Dividend2.95
Dividend Growth(5Y)5.3%
DP136.36%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-25%
Min EPS beat(2)-26.06%
Max EPS beat(2)-23.94%
EPS beat(4)0
Avg EPS beat(4)-20.18%
Min EPS beat(4)-26.06%
Max EPS beat(4)-15.32%
EPS beat(8)0
Avg EPS beat(8)-12.22%
EPS beat(12)0
Avg EPS beat(12)-10.75%
EPS beat(16)1
Avg EPS beat(16)-9.6%
Revenue beat(2)0
Avg Revenue beat(2)-2.46%
Min Revenue beat(2)-2.79%
Max Revenue beat(2)-2.12%
Revenue beat(4)0
Avg Revenue beat(4)-1.72%
Min Revenue beat(4)-2.79%
Max Revenue beat(4)-0.41%
Revenue beat(8)1
Avg Revenue beat(8)-1.37%
Revenue beat(12)1
Avg Revenue beat(12)-1.51%
Revenue beat(16)4
Avg Revenue beat(16)-0.95%
PT rev (1m)-0.89%
PT rev (3m)-3.26%
EPS NQ rev (1m)14.66%
EPS NQ rev (3m)11.77%
EPS NY rev (1m)-1.05%
EPS NY rev (3m)-3.53%
Revenue NQ rev (1m)6.02%
Revenue NQ rev (3m)4.6%
Revenue NY rev (1m)-0.39%
Revenue NY rev (3m)-1.37%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.06 | ||
| Fwd PE | 22.71 | ||
| P/S | 4.43 | ||
| P/FCF | 23.67 | ||
| P/OCF | 18.59 | ||
| P/B | 7.66 | ||
| P/tB | N/A | ||
| EV/EBITDA | 15.75 |
EPS(TTM)2.38
EY3.02%
EPS(NY)3.46
Fwd EY4.4%
FCF(TTM)3.32
FCFY4.22%
OCF(TTM)4.23
OCFY5.38%
SpS17.76
BVpS10.27
TBVpS-8.72
PEG (NY)0.72
PEG (5Y)N/A
Graham Number23.45
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.52% | ||
| ROE | 22.55% | ||
| ROCE | 18.32% | ||
| ROIC | 12.65% | ||
| ROICexc | 12.94% | ||
| ROICexgc | 47.68% | ||
| OM | 27.52% | ||
| PM (TTM) | 13.04% | ||
| GM | 67.97% | ||
| FCFM | 18.72% |
ROA(3y)9.32%
ROA(5y)14.2%
ROE(3y)26.12%
ROE(5y)38.84%
ROIC(3y)13.59%
ROIC(5y)18.83%
ROICexc(3y)13.93%
ROICexc(5y)19.56%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)19.68%
ROCE(5y)29.74%
ROICexgc growth 3Y-12.46%
ROICexgc growth 5Y-4.64%
ROICexc growth 3Y-7.18%
ROICexc growth 5Y-21.95%
OM growth 3Y-3.48%
OM growth 5Y-2.71%
PM growth 3Y-14.46%
PM growth 5Y-10.44%
GM growth 3Y-0.39%
GM growth 5Y-0.01%
F-Score6
Asset Turnover0.58
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.24 | ||
| Debt/FCF | 4.34 | ||
| Debt/EBITDA | 2.2 | ||
| Cap/Depr | 98.21% | ||
| Cap/Sales | 5.12% | ||
| Interest Coverage | 9.3 | ||
| Cash Conversion | 72.84% | ||
| Profit Quality | 143.51% | ||
| Current Ratio | 1.61 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 3.98 |
F-Score6
WACC5.78%
ROIC/WACC2.19
Cap/Depr(3y)106.21%
Cap/Depr(5y)137.78%
Cap/Sales(3y)5.05%
Cap/Sales(5y)6.06%
Profit Quality(3y)77.98%
Profit Quality(5y)77.41%
High Growth Momentum
Growth
EPS 1Y (TTM)-20.93%
EPS 3Y-7.04%
EPS 5Y-2.02%
EPS Q2Q%-20.03%
EPS Next Y45.69%
EPS Next 2Y27.02%
EPS Next 3Y21.55%
EPS Next 5Y16.78%
Revenue 1Y (TTM)3.12%
Revenue growth 3Y7.27%
Revenue growth 5Y8.49%
Sales Q2Q%0.1%
Revenue Next Year5.7%
Revenue Next 2Y6.56%
Revenue Next 3Y6.93%
Revenue Next 5Y7.1%
EBIT growth 1Y5.27%
EBIT growth 3Y3.54%
EBIT growth 5Y5.55%
EBIT Next Year28.29%
EBIT Next 3Y14.66%
EBIT Next 5Y12.27%
FCF growth 1Y268.5%
FCF growth 3Y9.61%
FCF growth 5Y6.39%
OCF growth 1Y140.59%
OCF growth 3Y9.24%
OCF growth 5Y6.9%
COLOPLAST-B / CBHD.DE FAQ
What is the ChartMill fundamental rating of COLOPLAST-B (CBHD.DE) stock?
ChartMill assigns a fundamental rating of 5 / 10 to CBHD.DE.
What is the valuation status for CBHD stock?
ChartMill assigns a valuation rating of 5 / 10 to COLOPLAST-B (CBHD.DE). This can be considered as Fairly Valued.
Can you provide the profitability details for COLOPLAST-B?
COLOPLAST-B (CBHD.DE) has a profitability rating of 7 / 10.
Can you provide the financial health for CBHD stock?
The financial health rating of COLOPLAST-B (CBHD.DE) is 4 / 10.
What is the expected EPS growth for COLOPLAST-B (CBHD.DE) stock?
The Earnings per Share (EPS) of COLOPLAST-B (CBHD.DE) is expected to grow by 45.69% in the next year.